National Institute of General Medical Sciences; Notice of Meeting, 73791 [2021-28096]

Download as PDF Federal Register / Vol. 86, No. 246 / Tuesday, December 28, 2021 / Notices Dated: December 21, 2021. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2021–28150 Filed 12–27–21; 8:45 am] BILLING CODE 4140–01–P (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: December 21, 2021. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2021–28096 Filed 12–27–21; 8:45 am] National Institutes of Health BILLING CODE 4140–01–P National Institute of General Medical Sciences; Notice of Meeting khammond on DSKJM1Z7X2PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Advisory General Medical Sciences Council. The meeting will be open to the public as indicated below, with a short public comment period at the end. The open session will be videocast and can be accessed from the NIH Videocasting and Podcasting website (https:// www.nigms.nih.gov/about-nigms/whatwe-do/advisory-council). The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory General Medical Sciences Council. Date: September 15, 2022. Open: 9:30 a.m. to 1:30 p.m. Agenda: For the discussion of program policies and issues; opening remarks; report of the Director, NIGMS; and other business of the Council. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892 (Virtual Meeting). Closed: 1:30 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Erica L. Brown, Ph.D., Director, Division of Extramural Activities, National Institute of General Medical Sciences, National Institutes of Health, Natcher Building, Room 2AN24F, Bethesda, MD 20892, 301–594–4499, erica.brown@ nih.gov. Information is also available on the Institute’s/Center’s home page: https:// www.nigms.nih.gov/About/Council, where an agenda and any additional information for the meeting will be posted when available. VerDate Sep<11>2014 22:45 Dec 27, 2021 Jkt 256001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of meetings of the National Diabetes and Digestive and Kidney Diseases Advisory Council. The meetings will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council. Date: September 7–8, 2022. Open: September 07, 2022, 10:00 a.m. to 1:30 p.m. Agenda: To present the Director’s Report and other scientific presentations. Place: National Institutes of Health, Building 31, C-Wing 6th Floor Conference Center, Conference Rooms C, D&E, and F&G, 31 Center Drive, Bethesda, MD 20892. Closed: September 08, 2022, 1:30 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, C-Wing 6th Floor Conference Center, Conference Rooms C, D&E, and F&G, 31 Center Drive, Bethesda, MD 20892. PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 73791 Contact Person: Karl F. Malik, Ph.D., Director Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452, Bethesda, MD 20892, (301) 594–4757, malikk@ niddk.nih.gov. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council Diabetes, Endocrinology and Metabolic Diseases Subcommittee. Date: September 7–8, 2022. Open: September 08, 2022, 10:00 a.m. to 11:30 a.m. Agenda: To review the Division’s scientific and planning activities. Place: National Institutes of Health, Building 31, C-Wing 6th Floor Conference Center, Conference Rooms C, D&E, and F&G, 31 Center Drive, Bethesda, MD 20892. Closed: September 08, 2022, 11:45 a.m. to 1:15 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, C-Wing 6th Floor Conference Center, Conference Rooms C, D&E, and F&G, 31 Center Drive, Bethesda, MD 20892. Contact Person: Karl F. Malik, Ph.D., Director Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452, Bethesda, MD 20892, (301) 594–4757, malikk@niddk.nih.gov. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council Digestive Diseases and Nutrition Subcommittee. Date: September 7–8, 2022. Open: September 08, 2022, 10:00 a.m. to 11:30 a.m. Agenda: To review the Division’s scientific and planning activities. Place: National Institutes of Health Building 31, C-Wing 6th Floor Conference Center, Conference Rooms C, D&E, and F&G, 31 Center Drive, Bethesda, MD 20892. Closed: September 08, 2022, 11:45 a.m. to 1:15 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Building 31, Conference Rooms C, D&E, and F&G, 31 Center Drive, Bethesda, MD 20892. Contact Person: Karl F. Malik, Ph.D., Director, Division of Extramural Activities, National Institutes of Diabetes and Digestive and Kidney Diseases, 6707 Democracy Boulevard, Room 7329, MSC 5452, Bethesda, MD 20892, (301) 594–4757 malikk@ niddk.nih.gov. Name of Committee: National Diabetes and Digestive and Kidney Diseases Advisory Council; Kidney, Urologic and Hematologic Diseases Subcommittee. Date: September 7–8, 2022. Open: September 08, 2022, 10:00 a.m. to 12:00 p.m. Agenda: To review the Division’s scientific and planning activities. Place: National Institutes of Health, Building 31, C-Wing, 6th Floor Conference Center, Conference Rooms C, D&E, and F&G, 31 Center Drive, Bethesda, MD 20892. Closed: September 08, 2022, 12:15 p.m. to 1:15 p.m. E:\FR\FM\28DEN1.SGM 28DEN1

Agencies

[Federal Register Volume 86, Number 246 (Tuesday, December 28, 2021)]
[Notices]
[Page 73791]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28096]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of General Medical Sciences; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the National Advisory 
General Medical Sciences Council.
    The meeting will be open to the public as indicated below, with a 
short public comment period at the end. The open session will be 
videocast and can be accessed from the NIH Videocasting and Podcasting 
website (https://www.nigms.nih.gov/about-nigms/what-we-do/advisory-council).
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory General Medical Sciences 
Council.
    Date: September 15, 2022.
    Open: 9:30 a.m. to 1:30 p.m.
    Agenda: For the discussion of program policies and issues; 
opening remarks; report of the Director, NIGMS; and other business 
of the Council.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Bethesda, MD 20892 (Virtual Meeting).
    Closed: 1:30 p.m. to 4:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Erica L. Brown, Ph.D., Director, Division of 
Extramural Activities, National Institute of General Medical 
Sciences, National Institutes of Health, Natcher Building, Room 
2AN24F, Bethesda, MD 20892, 301-594-4499, [email protected].

    Information is also available on the Institute's/Center's home 
page: https://www.nigms.nih.gov/About/Council, where an agenda and 
any additional information for the meeting will be posted when 
available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.859, 
Biomedical Research and Research Training, National Institutes of 
Health, HHS)

    Dated: December 21, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-28096 Filed 12-27-21; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.